[Evaluation of the activity of mebendazole in taeniasis caused by Hymenolepis nana in Tunisia].
Forty-two Tunisian patients suffering from Hymenolepis nana infection, were treated with 500 mg tablets of mebendazole, 3 times a day, 3 consecutive days for 5 patients (group I) and 4 consecutive days for 37 patients (group II). The faeces were examined during the third and fifth week, after treatment. 18 (42.8%) patients, 2 from group I and 16 from group II, were cured. The tolerance of the product was excellent and there were no adverse side-effects.
D000293:Adolescent; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D002648:Child; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D006925:Hymenolepiasis / Q000175:diagnosis / Q000188:drug therapy*; D006926:Hymenolepis; D008297:Male; D008463:Mebendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D010270:Parasite Egg Count; D014416:Tunisia
D001562:Benzimidazoles; D008463:Mebendazole
Evaluation de l'activité du mébendazole dans la taeniase a Hymenolepis nana en Tunisie.